Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates

Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates This post hoc analysis of data from a randomized clinical trial assesses whether high-dose erythropoietin given within 24 hours of birth through postmenstrual age of 32 completed weeks will decrease the need for blood transfusions in extremely low gestational age neonates. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Pediatrics American Medical Association

Loading next page...
 
/lp/american-medical-association/effect-of-high-dose-erythropoietin-on-blood-transfusions-in-extremely-Xp01CmGTvK

References (52)

Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2168-6203
eISSN
2168-6211
DOI
10.1001/jamapediatrics.2020.2271
Publisher site
See Article on Publisher Site

Abstract

This post hoc analysis of data from a randomized clinical trial assesses whether high-dose erythropoietin given within 24 hours of birth through postmenstrual age of 32 completed weeks will decrease the need for blood transfusions in extremely low gestational age neonates.

Journal

JAMA PediatricsAmerican Medical Association

Published: Oct 17, 2020

There are no references for this article.